News
- Elanco Announces Agreement to Acquire Kindred BiosciencesJune 16, 2021 6:30 AM EDT
- Kindred Biosciences Announces Positive Results from Pivotal Efficacy Study of Parvovirus Monoclonal Antibody for the Prevention of Deaths in Dogs Infected by ParvovirusJune 2, 2021 8:31 AM EDT
- Kindred Biosciences to Present at Stifel 2021 Virtual Jaws & Paws Conference and LD Micro Invitational XIMay 25, 2021 8:42 AM EDT
Events
- Tuesday, June 8, 2021 from 1:30 PM to 1:55 PM EDT
- Wednesday, June 2, 2021 from 11:00 AM to 11:25 AM EDT
- Tuesday, May 11, 2021 4:30 PM EDT
|
KindredBio proudly supports
Rabies Free Africa
Press Releases
Keyword Search
Elanco Announces Agreement to Acquire Kindred Biosciences
June 16, 2021
Bolt-on Acquisition Accelerates Elanco’s Expansion in Pet Health Elanco to host...
Kindred Biosciences Announces Positive Results from Pivotal Efficacy Study of Parvovirus Monoclonal Antibody for the Prevention of Deaths in Dogs Infected by Parvovirus
June 2, 2021
- Study demonstrated 100% survival in dogs treated with KIND-030, even in the abs...
Kindred Biosciences to Present at Stifel 2021 Virtual Jaws & Paws Conference and LD Micro Invitational XI
May 25, 2021
SAN FRANCISCO , May 25, 2021 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: K...
Kindred Biosciences Announces First Quarter 2021 Financial Results
May 11, 2021
SAN FRANCISCO , May 11, 2021 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: ...
Kindred Biosciences to Announce First Quarter 2021 Financial Results
May 3, 2021
Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time/1:30 p.m. P...
Kindred Biosciences Announces Acceptance of Parvovirus Antibody Prophylaxis Study Data and Approval of Efficacy Indication
April 28, 2021
USDA approves the claim that the product is effective for the passive immunizatio...
Kindred Biosciences Unveils Positive Results from its Long-Acting Interleukin-31 Antibody PK Study
April 20, 2021
- Engineered antibody demonstrates up to three-fold increase in half-life SAN FRA...
Kindred Biosciences Announces Fourth Quarter and Full Year 2020 Financial Results
March 16, 2021
SAN FRANCISCO , March 16, 2021 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ...
Kindred Biosciences to Announce Fourth Quarter and Full Year 2020 Financial Results
March 8, 2021
Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time/1:30 p.m. P...
Kindred Biosciences to Present at Barclays Global Healthcare Conference and H.C. Wainwright Global Life Sciences Conference
March 2, 2021
SAN FRANCISCO , March 2, 2021 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ...
Kindred Biosciences Announces Submission of Parvovirus Monoclonal Antibody Data for Prophylactic Indication
February 25, 2021
SAN FRANCISCO , Feb. 25, 2021 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: ...
Kindred Biosciences to Present at the BofA Securities Animal Health Virtual Summit
February 16, 2021
SAN FRANCISCO , Feb. 16, 2021 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ...
Kindred Biosciences Announces Two New Appointments to Board of Directors
February 9, 2021
SAN FRANCISCO , Feb. 9, 2021 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: K...